Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia”

5,192 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,192 results

Testing effectiveness (Phase 2)Looking for participantsNCT05583721
What this trial is testing

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 40
Not applicableStudy completedNCT05469230
What this trial is testing

Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia

Who this might be right for
Cognitive ChangeBeta-ThalassemiaFatigue+1 more
Cairo University 168
Testing effectiveness (Phase 2)Study completedNCT01749514
What this trial is testing

Study of Luspatercept for the Treatment of Anemia in Patients With Myelodysplastic Syndrome (MDS) (MK-6143-001)

Who this might be right for
Anemia
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 116
Testing effectiveness (Phase 2)Study completedNCT00145626
What this trial is testing

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplasia+2 more
St. Jude Children's Research Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06421636
What this trial is testing

Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

Who this might be right for
Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals 19
Not applicableStudy completedNCT03488264
What this trial is testing

Stigma, Self-management, & Quality of Life in SCD

Who this might be right for
Sickle Cell DiseaseQuality of LifeStigma, Social+1 more
Duke University 102
Large-scale testing (Phase 3)Study completedNCT00313716
What this trial is testing

Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury

Who this might be right for
AnemiaTraumatic Brain Injury
Claudia Sue Robertson 200
Not applicableStudy completedNCT02301026
What this trial is testing

A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency

Who this might be right for
Anaemia in Chronic Kidney Disease
Pharmacosmos A/S 209
Not applicableUnknownNCT02662699
What this trial is testing

Clinical Signs and Symptoms of Anemia in Patients Over 75 Years

Who this might be right for
Anemia
University Hospital, Strasbourg, France 40
Large-scale testing (Phase 3)UnknownNCT00303784
What this trial is testing

Prostate Adenocarcinoma TransCutaneous Hormones

Who this might be right for
AnemiaCardiovascular ComplicationsHot Flashes+2 more
University College, London 2,200
Not applicableStudy completedNCT02068755
What this trial is testing

Blood Products in Cardiac Surgery

Who this might be right for
AnemiaRenal ImpairmentThrombocytopenia
University of Turku 31,000
Early research (Phase 1)Active Not RecruitingNCT03531736
What this trial is testing

T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia

Who this might be right for
Myeloid Diseases
Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)UnknownNCT02050971
What this trial is testing

Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates

Who this might be right for
Anemia, NeonatalIntracranial HemorrhagesNecrotizing Enterocolitis+3 more
Pomeranian Medical University Szczecin 40
Post-approval studies (Phase 4)Ended earlyNCT02210949
What this trial is testing

Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery

Who this might be right for
Heart; Dysfunction Postoperative, Cardiac SurgeryAnemia, Iron-Deficiency
Catharina Ziekenhuis Eindhoven 7
Not applicableStudy completedNCT05752955
What this trial is testing

SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth

Who this might be right for
Anemia of PregnancyGestational DiabetesGestational Hypertension+4 more
The George Institute 3,446
Testing effectiveness (Phase 2)WithdrawnNCT03801889
What this trial is testing

SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias

Who this might be right for
Iron OverloadBeta-Thalassemia
Abfero Pharmaceuticals, Inc
Early research (Phase 1)Study completedNCT00641589
What this trial is testing

Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Post-approval studies (Phase 4)Ended earlyNCT00440063
What this trial is testing

NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.

Who this might be right for
Anemia
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT03591406
What this trial is testing

To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia

Who this might be right for
Iron Deficiency Anemia
Vifor (International) Inc. 371
Large-scale testing (Phase 3)Study completedNCT01145638
What this trial is testing

Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Who this might be right for
Non-myeloid MalignanciesChemotherapy Induced Anaemia
Pharmacosmos A/S 350
Load More Results